Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - large image1
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - image1
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - image2
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - image3
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - image4
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - image5
High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss buy - image6

High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss

597 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical grade

Content:

99%

Port:

GuangZhou

Brand:

XKY

Packaging:

5mg/vial,10mg/vial,10vials/box

Sample Available:

Yes

Price valid (until):

2026-07-25

Company Type:
Trader
Location:
China
Payment Terms:
L/C,O/A,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Tirzepatide,Retatrutide,Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail   



    Sales manager:Mandy
    whatsapp:+8617268825104
    Email:Mandy@xtmingheng.com


    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 1

    Products Name:
    Tirzepatide
    CAS No.: 2023788-19-2
    Purity: 99%
    Appearance: White Lyophilized powder
    Molecular Weight: 4813.527g/mol
    Storage: Store at -20°C

    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 2

    Product Description
    Tirzepatide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP, aka: gastric inhibitory polypeptide) dual receptor agonist, administered once a week. both GLP-1 and GIP belong to the intestinal proinsulin, which is a polypeptide secreted by the mucous membranes of the gastrointestinal tract of the human body. the former can bind with the receptor on the pancreatic islet cell and stimulate the secretion of islet Chemicalbookin, which in turn produces a hypoglycemic effect, as well as delaying gastric emptying and suppressing appetite, thereby controlling body weight; whereas the latter has the functions of inhibiting gastric acid and pepsin secretion, stimulating insulin release, and inhibiting gastric peristalsis and emptying, which can complement the GLP-1 receptor agonist effect. tirzepatide combines the effects of 2 types of insulinotropic agents in a a single molecule and represents a novel class of drugs for the treatment of type 2 diabetes.
    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 3
    Tirzepatide shares a similar sequence to semaglutide, with the lys side chain of the sequence bearing a PEG modification, which is a functional group of the peptide, as well as the ability to increase the water solubility of the sequence.The primary physiological function of Tirzepatide is that of a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor. It is being developed for the treatment of type 2 diabetes mellitus and is already in the clinical phase.A large study enrolled 2539 adults with at least one complication of obesity (excluding diabetes) and a body mass index (BMI) ≥30kg/m2 or ≥27kg/m2. All subjects were randomly divided into 5mg, 10mg, 15mg and placebo groups in equal proportions. The results showed that at 72 weeks, the weight of each group decreased by 16.1kg, 22.2kg, 23.6kg, and 2.4kg, respectively [2]. The weight loss effect of tepoxetine is comparable to that of bariatric surgery.
    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 4

    1.Helps slow food leaving your stomach
    2.Helps prevent your liver from making too much sugar
    3.Helps the pancreas produce more insul when your blood sugar levels are high
    4.Can help control blood glucose
    5.Can reduce hyperglycemia, especially after meals
    6.Can reduce fasting insul and fasting glucose
    7.Can reduce hemoglobin A1c
    8.Can decrease appetite and caloric intake, while inhibiting weight gain
    9.Has been shown to lower triglyceride levels and oxidative stress from high LDL


    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 5

    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 6 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 7 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 8


      Company Profile



    Xingtai xinkaiyue Technology Co., Ltd. was founded in 2019 has strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. We effectively promote joint ventures and cooperation with major enterprises and manufacturers, and serve the society and the majority of users with the idea of industrialized development. We always adhere to the market demand-oriented, and constantly synthesize new chemical products and pharmaceutical intermediates with high technical content, mainly exported to the United States, India, South Africa, Nigeria and many other countries and regions, with rich experience in export, to ensure the safety of transportation, and to be able to let every customer receive the goods safely as early as possible.

    Related certifications

      


    OPTIMIZED, AUTOMATED HIGH-YIELD PRODUCTION

    Shop Buy Weight Reduction Peptide Tirzetapide Tirze Injection Lyze-Dried Powder Vials 5mg 10mg 15mg CAS 2023788 19 2 Wholesale Price-Detailed Image 5 Shop Buy Weight Reduction Peptide Tirzetapide Tirze Injection Lyze-Dried Powder Vials 5mg 10mg 15mg CAS 2023788 19 2 Wholesale Price-Detailed Image 6 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 11


    ROBUST PROCESSES AND SUPPLY SECURITY

    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 12

    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 13




      Why choose us




    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 14 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 15 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 16 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 17

    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 18 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 19



    Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 20 Shop High Quality 99% Purity GLP-1 Injection 30mg Peptide CAS 2023788-19-2 Tirzepatide for Weight Loss-Detailed Image 21

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Peptides

    Location:

    Shop No. 47, Jixin Plaza, No. 26 Renmin Avenue, Renmin Street, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    L/C,O/A,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2019

    Haikou Mingheng Technology Co., Ltd. is a modern and advanced enterprise specializing in the production and export of pharmaceutical intermediates, plant extracts, and other products. Products are widely used in health products, peptides and other fields. Our plant covers an area of 1000 m². The proposed workshop will be built according to GMP standards. We provide our customers with quality products and first-class service. Now, we can provide G-KG service to our customers.

    • High-Quality Peptides: Our company specializes in premium-grade peptides, ensuring the highest standards of purity and efficacy. Each product undergoes rigorous testing to guarantee superior quality and performance.

    • Cutting-Edge Technology: We leverage the latest advancements in peptide synthesis and production technology. Our state-of-the-art facilities and innovative processes enable us to deliver peptides with exceptional precision and consistency.

    • Custom Solutions: We offer tailored peptide solutions to meet the specific needs of our clients. Whether you require bespoke formulations or custom quantities, our experienced team is dedicated to providing personalized support and solutions.

    • Extensive Expertise: With years of experience in the peptide industry, our team of experts is well-versed in the complexities of peptide development and applications. We are committed to providing insightful guidance and technical support to help you achieve your goals.

    • Comprehensive Product Range: Our diverse portfolio of peptide products covers a wide range of applications, including research, pharmaceutical development, and cosmetic formulations. This allows us to cater to various industries and meet different customer needs.

      Company Profile

     




  • Inquiry History
    597 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    1  Dec 2, 2025
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Philippines

    Tirzepatide

    15 MG Feb 25, 2026
    Canada

    Tirzepatide

    1 MG Jan 15, 2025
    United States

    Tirzepatide

    1 G Sep 1, 2026
    United States

    Tirzepatide

    10 MG Sep 17, 2026
    United States

    Tirzepatide

    1000 MT Sep 9, 2026
    Italy

    Tirzepatide

    10 MG Aug 17, 2026
    United States

    Tirzepatide

    10 G Jul 29, 2026
    Turkey

    Tirzepatide

    10 PCS Jun 16, 2026
    United States

    Tirzepatide

    30 MG May 13, 2026
    Egypt

    Tirzepatide

    10 PCS May 12, 2026
    United States

    Tirzepatide

    10 G May 6, 2026
    Philippines

    Tirzepatide 15mg and 30mg

    20 PCS May 1, 2026
    Netherlands

    Tirzepatide

    10 MT Apr 19, 2026
    Pakistan

    TIRZEPATIDE

    100 G Mar 3, 2026
    United States

    Tirzepatide

    2 MG Feb 9, 2026
    Bolivia

    TIZERPATIDA

    1 KG Feb 5, 2026
    Indonesia

    Tirzepatide

    200 MT Jan 15, 2026
    Philippines

    tirzepatide

    9 MG Nov 25, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.